Enabling 4D Proteomics and Epiproteomics

Bruker Daltonics Managing Director and Executive Vice President Dr. Rohan Thakur joins us to discuss how the company's innovative analytics tools are enabling 4D proteomics, epiproteomics, and beyond.

Rohan Thakur, Ph.D.

Dr. Rohan Thakur, Managing Director and Executive Vice President, Life Sciences Mass Spectrometry, Bruker Daltonics GmbH & Co. KG, Bremen, joined Bruker 2010 as General Manager for the CAM MS team in Fremont, CA, being promoted consequently to Vice President Quadrupole Business and Senior Vice President within his first five years before taking over his new role. Dr. Thakur has over 20 years of experience in mass spectrometry, including 14 years in applications and MS development and is also owner of several patents in the field of mass spectrometry. During his career he held positions as Director Global Marketing for mass spectrometry solutions at Thermo and was Director of Drug Discovery at a Pharma CRO for 2 years before joining Bruker. Dr. Thakur received his Ph.D. in Chemistry from Kansas State University and did post-doctoral studies at Rutgers University, where his work involved using high-resolution MS analysis to prove the formation of ring-opened benzene metabolite-DNA and protein adducts.

Q: